Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.19 +2.6%	$19.00 ➝ $14.00	Equal Weight
ABF Associated British Foods	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,843.50 -0.9%	GBX 1,700 ➝ GBX 1,645	Neutral
ACVA ACV Auctions	Downgraded by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Pierce Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.44 +44.5%		Buy ➝ Hold
ADAM Adamas Trust	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Weaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.04 -1.3%	$10.00	Buy
ADBE Adobe	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%		Market Perform
ADBE Adobe	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$315.00	Outperform
ADBE Adobe	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$230.00 ➝ $250.00	Neutral
ADBE Adobe	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Altmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%		Neutral
ADBE Adobe	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$230.00 ➝ $270.00	Market Perform
ADBE Adobe	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Arti Vula Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$340.00 ➝ $315.00	Overweight
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
ADBE Adobe	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$301.00 ➝ $250.00	Neutral
ADBE Adobe	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$315.00
ADBE Adobe	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$285.00 ➝ $275.00	Hold
ADBE Adobe	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%		Market Perform
ADBE Adobe	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%		Underweight
ADBE Adobe	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$250.00 ➝ $270.00	Overweight
ADBE Adobe	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$240.00 ➝ $250.00	Neutral
ADBE Adobe	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$254.43 +2.3%	$250.00
ADBE Adobe	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.43 +2.3%	$225.00 ➝ $255.00	Neutral
ALGT Allegiant Travel	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.18 +2.8%	$145.00 ➝ $115.00	Overweight
ALK Alaska Air Group	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.17 +2.6%	$65.00 ➝ $52.00	Overweight
AME AMETEK	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Buscaglia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.88 +3.3%	$280.00 ➝ $290.00	Outperform
AMN AMN Healthcare Services	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Silber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.34 +0.9%	$38.00 ➝ $40.00	Outperform
ANGI Angi	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Smilek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.69 +0.8%		Underweight
ANP Anpario	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 460 -2.6%	GBX 570 ➝ GBX 600	Buy
APAM Artisan Partners Asset Management	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.98 -4.3%	$37.00	Hold
APP AppLovin	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$323.82 +3.0%		Buy
ARBE Arbe Robotics	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Gianarikas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.79 +3.8%	$2.00
ATO Atmos Energy	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeremy Tonet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$164.00 -0.5%	$198.00 ➝ $180.00	Overweight ➝ Neutral
AUR Aurora Innovation	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ravi Shanker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.45 +1.8%	$14.00 ➝ $18.00	Overweight
AVAV AeroVironment	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Epstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.03 -1.4%	$225.00 ➝ $185.00	Buy
AXTA Axalta Coating Systems	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.34 +0.9%	$47.00	Sector Weight ➝ Overweight
AYA Aya Gold & Silver	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$38.61 -1.8%	C$39.00 ➝ C$56.00	Buy
BBOT BridgeBio Oncology Therapeutics	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Priyanka Grover Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.02 -9.1%	$25.00 ➝ $23.00	Overweight
BBSEY BB Seguridade Participacoes	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.83 -3.3%		Sell
BFH Bread Financial	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$106.73 -0.1%	$115.00
BFH Bread Financial	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Donald Fandetti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.73 -0.1%	$115.00	Equal Weight
BFLY Butterfly Network	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Jennings Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.36 +3.3%	$10.00	Buy
BIRK Birkenstock	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.05 +1.2%		Buy
BIRK Birkenstock	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.05 +1.2%	$55.00	Buy
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
BLDR Builders FirstSource	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.54 +2.7%	$65.00 ➝ $63.00	Equal Weight
BMXMF bioMerieux	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$86.11		Underweight
BOKF BOK Financial	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Najarian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.49 +0.2%	$143.00	Market Perform
BROS Dutch Bros	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.11 +1.5%	$73.00 ➝ $59.00	Buy
BYDDF BYD	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.18 +1.5%	$20.00
BYN Banyan Gold	Target Set by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.98 +1.5%	C$3.00	Buy
CAR Avis Budget Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Percoco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.75 -2.4%	$99.00 ➝ $95.00	Equal Weight
CASY Casey's General Stores	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$613.63 -2.2%	$775.00	Outperform
CBLL CeriBell	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.54 +0.5%	$30.00	Buy
CDNS Cadence Design Systems	Initiated by	FBN Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$291.66 +2.4%	$375.00	Outperform
CHEF Chefs' Warehouse	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.27 +1.4%	$123.00 ➝ $131.00	Buy
CHWY Chewy	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Doug Anmuth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.32 -3.6%	$29.00 ➝ $24.00	Overweight ➝ Neutral
CHWY Chewy	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Steiger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.32 -3.6%	$34.00 ➝ $30.00	Buy
CLW Clearwater Paper	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Staphos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.29 +3.0%	$24.00 ➝ $25.00	Neutral
CLX Clorox	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.68 -1.2%	$102.00 ➝ $90.00	Equal Weight
CLX Clorox	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.68 -1.2%	$100.00 ➝ $97.00	Neutral
CLX Clorox	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.68 -1.2%		Neutral
CNC Centene	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$65.66 +0.4%		Overweight
CNC Centene	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$65.66 +0.4%		Buy
CNM Core & Main	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Pettinari Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.75 -0.2%	$53.00 ➝ $46.00	Neutral
CPK Chesapeake Utilities	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriel Moreen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.18 +0.5%	$150.00	Outperform
CPRT Copart	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Kennison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.88 -2.8%	$42.00 ➝ $38.00	Outperform
CPRT Copart	Upgraded by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.88 -2.8%	$40.00	Market Perform ➝ Outperform
CRH CRH	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Angel Castillo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.83 +1.3%	$139.00	Overweight
CRL Charles River Laboratories International	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$276.57 +1.3%	$320.00	Outperform
CRM Salesforce	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$248.84 +2.4%	$240.00
CRM Salesforce	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$248.84 +2.4%		Buy
CRM Salesforce	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$248.84 +2.4%	$275.00
CTEC ConvaTec Group	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 215.80 -0.9%	GBX 340 ➝ GBX 335	Buy
CVS CVS Health	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.06 -1.3%		Overweight
CYTK Cytokinetics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$74.66 +1.4%		Overweight
DAL Delta Air Lines	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.01 +2.3%	$105.00 ➝ $95.00	Overweight
DC Dakota Gold	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.80 -1.8%		Buy
DDOG Datadog	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.67 -0.5%	$260.00 ➝ $275.00	Outperform
DECK Deckers Outdoor	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.36 +1.8%		Buy
DFTX Definium Therapeutics	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Abrahams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.02 +3.4%	$66.00	Outperform
DHI D.R. Horton	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.88 +1.7%	$155.00 ➝ $145.00	Equal Weight
DNTH Dianthus Therapeutics	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Cheng Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.43 +4.0%	$135.00	Overweight
DRI Darden Restaurants	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dennis Geiger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$209.02 +0.7%		Buy
DRI Darden Restaurants	Target Raised by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Salera Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$209.02 +0.7%	$216.00 ➝ $220.00	Equal Weight
DRI Darden Restaurants	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jon Tower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$209.02 +0.7%	$245.00 ➝ $248.00	Buy
DSGX The Descartes Systems Group	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Krishnaratne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.31 +5.6%	$95.00 ➝ $98.00	Sector Outperform
DSGX The Descartes Systems Group	Target Raised by	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$75.31 +5.6%	$95.00 ➝ $98.00	Sector Outperform
DXLG Destination XL Group	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.65 -0.8%	$1.50 ➝ $1.25	Buy
EAT Brinker International	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$213.04 -0.8%	$260.00 ➝ $240.00	Neutral
ELCO Eleco	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 229	GBX 205 ➝ GBX 235	Hold
ELS Equity Lifestyle Properties	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Hau Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.11 -0.3%	$67.00 ➝ $64.00	Hold
EMP.A Empire	Target Lowered by	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$45.59 -1.7%	C$50.00 ➝ C$48.00	Sector Perform
EMP.A Empire	Target Lowered by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$45.59 -1.7%	C$56.00 ➝ C$54.00	Sector Perform
EMP.A Empire	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$45.59 -1.7%	C$57.00 ➝ C$53.00	Buy
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
EMP.A Empire	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$45.59 -1.7%	C$53.00 ➝ C$52.00	Hold
ENOG Energean	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 797 +0.1%	GBX 765 ➝ GBX 780	Hold
ESI Element Solutions	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Duffy Fischer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.06 -0.3%	$44.00	Buy
ESTC Elastic	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.24 -0.3%	$125.00	Outperform
EVPL Everplay Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 347.96 +18.8%	GBX 430	Buy
EW Edwards Lifesciences	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.35 -2.8%	$110.00	Buy
EXEL Exelixis	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.52 -1.6%		Outperform
EYE National Vision	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.56 +2.5%	$27.00
FBIN Fortune Brands Innovations	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.53 +2.0%	$52.00 ➝ $48.00	Overweight
FBRT Franklin BSP Realty Trust	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Weaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.81 +1.6%	$12.00	Buy
FDS FactSet Research Systems	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Faiza Alwy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$259.28 -1.4%	$280.00 ➝ $299.00	Hold
FFIN First Financial Bankshares	Initiated by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Najarian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.08 +0.0%	$36.00	Outperform ➝ Market Perform
FIS Fidelity National Information Services	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Carcache Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.93 -1.5%	$42.00	Neutral
FLNC Fluence Energy	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maheep Mandloi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.99 +3.0%	$15.00 ➝ $8.00	Underperform
FMC FMC	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.32 -6.3%	$16.00	Sector Weight ➝ Overweight
FOUR Shift4 Payments	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Perlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.40 +5.5%	$67.00	Outperform
GETY Getty Images	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cory Carpenter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.26 -2.6%		Underweight
GEV GE Vernova	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$953.67 +3.2%	$1,185.00
GFL GFL Environmental	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Schumm Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.54 +2.2%	$65.00	Buy
GMRS GMR Solutions	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Rossi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.89 +3.4%	$15.00 ➝ $16.00	Overweight
GPK Graphic Packaging	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Staphos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.58 +2.0%	$14.00 ➝ $13.00	Neutral
HAI Haivision Systems	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3.92 -2.5%	C$8.00 ➝ C$4.00	Buy ➝ Hold
HIMS Hims & Hers Health	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cory Carpenter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.31 -0.5%	$32.00	Neutral
HLMA Halma	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,634 +1.3%	GBX 3,660	Hold
HOOD Robinhood Markets	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.36 -0.9%	$155.00 ➝ $165.00	Market Outperform
HUBS HubSpot	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.35 +1.7%	$300.00	Outperform
HUBS HubSpot	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.35 +1.7%	$200.00 ➝ $225.00	Hold
HUN Huntsman	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.51 -0.3%	$14.00	Sector Weight ➝ Overweight
IBEX IBEX	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Koning Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.40 +5.7%	$35.00 ➝ $40.00	Neutral
IBP Installed Building Products	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.87 +2.1%	$245.00 ➝ $240.00	Equal Weight
IESC IES	Upgraded by	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sergey Glinyanov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$344.51 +7.8%	$440.00	Hold ➝ Buy
INCY Incyte	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$122.95 -0.3%		Neutral
INSP Inspire Medical Systems	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.95 +7.1%	$75.00 ➝ $80.00	Buy
INTU Intuit	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$321.12 +2.7%	$385.00	Outperform
IP International Paper	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.42 +0.4%	$46.00	Neutral ➝ Buy
IPCO International Petroleum	Target Set by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$35.71 -3.4%	C$38.00	Hold
JAZZ Jazz Pharmaceuticals	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$245.90 +2.3%	$315.00 ➝ $337.00	Buy
JBLU JetBlue Airways	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.41 +0.3%	$7.00 ➝ $5.00	Equal Weight
JEF Jefferies Financial Group	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brennan Hawken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.90 -3.8%	$60.00 ➝ $57.00	Market Perform
JEF Jefferies Financial Group	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.90 -3.8%	$65.00 ➝ $61.00	Neutral
JEF Jefferies Financial Group	Target Set by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brennan Hawken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.90 -3.8%	$57.00
JMKE Jersey Mike's	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.02 +0.7%	$29.00 ➝ $30.00	Buy
JMKE Jersey Mike's	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Francfort Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.02 +0.7%	$28.00 ➝ $29.00	Buy
KBH KB Home	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.93 +2.5%	$52.00 ➝ $50.00	Underweight
KDK Kodiak AI	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ravi Shanker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.88 +2.0%	$9.00	Equal Weight
KMB Kimberly-Clark	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lavery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$98.34 -0.1%	$121.00 ➝ $118.00	Overweight
KRSA Cyclerion Therapeutics	Initiated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.90 +29.9%	$55.00	Buy
LEGN Legend Biotech	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.84 -1.8%	$78.00 ➝ $74.00	Overweight
LEN Lennar	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.87 +2.5%	$85.00 ➝ $80.00	Equal Weight
LEU Centrus Energy	Target Set by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$154.06 -7.1%	$270.00
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
LFMD LifeMD	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Woods Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.02 -0.5%	$8.00	Buy
LH Labcorp	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.26 +1.1%	$361.00 ➝ $380.00	Buy
LH Labcorp	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Meehan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.26 +1.1%	$320.00 ➝ $330.00	Equal Weight
LIN Linde	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$465.58 +0.9%	$563.00	Outperform
LIN Linde	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$465.58 +0.9%		Outperform
LLOY Lloyds Banking Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 111.15 +1.9%	GBX 124	Outperform
LOVE Lovesac	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.58 -4.8%		Buy
LOVE Lovesac	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.58 -4.8%	$20.00 ➝ $18.00	Buy
LUV Southwest Airlines	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.30 +1.6%	$65.00 ➝ $58.00	Overweight
LYEL Lyell Immunopharma	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.04 -1.3%	$44.00	Buy
LYEL Lyell Immunopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.04 -1.3%		Buy
M Macy's	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.36 +4.2%		Neutral
MARA MARA	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.06 +5.5%	$20.00	Buy
MAS Masco	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.48 +1.2%	$87.00 ➝ $82.00	Overweight
MBOT Microbot Medical	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anderson Schock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.47 +0.4%	$4.00	Buy
MCD McDonald's	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$252.66 -0.2%	$300.00 ➝ $282.00	Hold
MCFT Mastercraft Boat	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Kennison Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.79 -3.8%	$30.00 ➝ $26.00	Neutral
META Meta Platforms	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Deepak Mathivanan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$649.31 +0.8%		Neutral
META Meta Platforms	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$649.31 +0.8%		Neutral
MGM MGM Resorts International	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.21 -1.3%	$50.00 ➝ $46.00	Neutral
MNKD MannKind	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Brayer Saunders Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.75 -1.2%	$8.00	Overweight
MNPR Monopar Therapeutics	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$111.38 +1.3%	$128.00 ➝ $145.00	Overweight
NBIX Neurocrine Biosciences	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Hung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$156.22 -0.2%	$182.00 ➝ $183.00	Equal Weight
NJR NewJersey Resources	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Sunderland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.26 -0.2%	$64.00 ➝ $63.00	Overweight
NOW ServiceNow	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.01 +1.4%	$115.00 ➝ $155.00	Buy
NU NU	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.50 -3.5%	$19.00	Buy
OC Owens Corning	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.48 +3.1%	$172.00 ➝ $150.00	Overweight
OKE ONEOK	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.78 +1.1%	$90.00 ➝ $93.00	Hold
OKE ONEOK	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.78 +1.1%	$93.00
OLN Olin	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.17 -0.8%	$26.00	Overweight
OMDA Omada Health	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.74 -8.2%	$28.00	Buy
OMDA Omada Health	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.74 -8.2%	$35.00	Buy
OMDA Omada Health	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.74 -8.2%	$25.00 ➝ $27.00	Overweight
ONB Old National Bancorp	Target Set by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Elian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.64 +0.1%	$32.00
ONB Old National Bancorp	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Elian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.64 +0.1%	$32.00	Overweight
ONON ON	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.37 +1.9%	$42.00
ORCL Oracle	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$245.00 ➝ $250.00	Buy
ORCL Oracle	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$220.00 ➝ $200.00	Buy
ORCL Oracle	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$250.00 ➝ $252.00	Overweight
ORCL Oracle	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%		Market Outperform
ORCL Oracle	Target Set by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$151.12 -1.2%	$285.00
ORCL Oracle	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$284.00	Overweight
ORCL Oracle	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$220.00 ➝ $195.00	Outperform
ORCL Oracle	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$175.00	Equal Weight
ORCL Oracle	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$225.00	Buy
ORCL Oracle	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$151.12 -1.2%	$190.00 ➝ $165.00	Sector Perform
OVID Ovid Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.70 +2.8%	$4.00 ➝ $5.00	Buy
OVID Ovid Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.70 +2.8%		Buy
PAF Pan African Resources	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 123.40 -2.2%	GBX 153	Buy
PANW Palo Alto Networks	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$328.73 -2.9%	$400.00	Outperform
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
PAYX Paychex	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$115.34 +0.1%	$98.00 ➝ $117.00	Hold
PDEX Pro-Dex	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.52 +4.5%	$70.00 ➝ $74.00	Buy
PFGC Performance Food Group	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.19 -0.2%	$120.00 ➝ $115.00	Buy
PHM PulteGroup	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.04 +1.4%	$150.00 ➝ $145.00	Overweight
PKG Packaging Corporation of America	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Staphos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$234.76 +1.0%	$280.00 ➝ $260.00	Buy
PLTR Palantir Technologies	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McPeake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.28 +0.9%	$225.00	Buy
PLTR Palantir Technologies	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.28 +0.9%	$200.00 ➝ $250.00	Buy
POOL Pool	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$172.82 -1.7%	$215.00 ➝ $185.00	Equal Weight
PPG PPG Industries	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.74 +0.7%	$133.00	Sector Weight ➝ Overweight
PPIH Perma-Pipe International	Target Raised by	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sergey Glinyanov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.24 +6.4%	$29.55 ➝ $38.00	Buy
PPLI People Incorporated Common Stock	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cory Carpenter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.46 -0.2%	$54.00	Overweight
QGEN Qiagen	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Beuchaw Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.27 +0.3%		Overweight
RBLX Roblox	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Martin Yang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.44 +1.2%		Outperform
RBLX Roblox	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.44 +1.2%		Buy
RBRK Rubrik	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.31 -2.9%	$90.00 ➝ $120.00	Outperform
RCUS Arcus Biosciences	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.63 -5.8%		Overweight
REAX Real Brokerage	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Erdner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.28 +9.4%	$40.00	Buy
REF Reformation	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Janine Stichter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.96 +6.2%		Buy
REF Reformation	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Irene Nattel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.96 +6.2%	$18.00	Outperform
REF Reformation	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.96 +6.2%	$20.00	Buy
RH RH	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Rakhlenko Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$220.00 ➝ $190.00	Buy
RH RH	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Benedict Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$165.00 ➝ $160.00	Neutral
RH RH	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristina Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$140.00 ➝ $155.00	Market Perform
RH RH	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Nardone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$156.00 ➝ $114.00	Underperform
RH RH	Reiterated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$90.00 ➝ $81.00	Underperform
RH RH	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Horvers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$212.00 ➝ $190.00	Overweight
RH RH	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Forbes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$200.00	Buy
RH RH	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$155.00 ➝ $154.00	Neutral
RH RH	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$190.00
RH RH	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$225.00 ➝ $175.00	Overweight
RH RH	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.47 +1.1%	$240.00 ➝ $210.00	Overweight
RKLB Rocket Lab	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Gesuale Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.61 +2.7%	$80.00	Outperform
RMTI Rockwell Medical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.26 +2.7%	$20.00	Buy
ROSE Rose Petroleum plc (ROSE.L)	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 335 +1.8%	GBX 450	Buy
RPM RPM International	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.23 +0.9%	$123.00	Sector Weight ➝ Overweight
S SentinelOne	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.77 -0.2%	$25.00	Outperform
SEDG SolarEdge Technologies	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Dendrinos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.66 -5.7%	$24.00 ➝ $30.00	Sector Perform
SEDG SolarEdge Technologies	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Arcaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.66 -5.7%	$35.00 ➝ $33.00	Equal Weight
SEDG SolarEdge Technologies	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maheep Mandloi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.66 -5.7%	$38.00 ➝ $40.00	Neutral
SEDG SolarEdge Technologies	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Strouse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.66 -5.7%	$37.00 ➝ $44.00	Neutral
SG Sweetgreen	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.17 +6.0%	$5.00 ➝ $6.00	Hold
SMR NuScale Power	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jon Windham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.79 -13.9%	$10.00 ➝ $6.00	Neutral ➝ Sell
SNN Smith & Nephew SNATS	Target Set by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.37 -0.9%	$33.88
SPCX SpaceX	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$149.86 +1.1%		Outperform
STIM Neuronetics	Initiated by	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.06 +1.5%		Buy
STIM Neuronetics	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Madison El-Saadi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.06 +1.5%	$5.00	Buy
STZ Constellation Brands	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Powers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.61 -1.0%	$150.00 ➝ $136.00	Hold
SUI Sun Communities	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Hau Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$114.45 -0.4%	$138.00 ➝ $136.00	Buy
SWK Stanley Black & Decker	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$89.34 +0.1%	$90.00 ➝ $95.00	Equal Weight
TCL.A Transcontinental	Target Raised by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$5.07 +4.3%	C$6.00 ➝ C$7.00	Outperform
TEL TE Connectivity	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Colin Langan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.48 +3.8%	$209.00 ➝ $220.00	Cautious
TEM Tempus AI	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.98 +0.4%	$56.00 ➝ $66.00	Buy
THS Tharisa	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 125.98 0.0%	GBX 220	Buy
TMDX TransMedics Group	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Matson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.61 -4.0%		Buy
TRGP Targa Resources	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabriel Moreen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$290.88 -0.4%	$300.00 ➝ $320.00	Outperform
TRN Trainline	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 193.75 +2.0%	GBX 400	Buy
TRP TC Energy	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maurice Choy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.56 -2.2%	$106.00	Outperform
TRZ Transat A.T.	Target Lowered by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.83 -9.0%	C$2.25 ➝ C$2.00	Hold
TRZ Transat A.T.	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.83 -9.0%	C$2.80 ➝ C$2.50	Hold
TRZ Transat A.T.	Target Lowered by	Scotia Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$1.83 -9.0%	C$2.00 ➝ C$1.65	Sector Underperform
TWLO Twilio	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Altmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.46 -1.6%	$285.00	Buy
UAL United Airlines	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$110.31 +3.6%	$175.00 ➝ $160.00	Overweight
ULCC Frontier Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.63 +1.7%	$7.00 ➝ $5.00	Underweight
UNFI United Natural Foods	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krisztina Katai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.17 +2.4%	$46.00 ➝ $53.00	Hold
UNTY Unity Bancorp	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jake Civiello Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.30 +2.0%	$68.00	Buy
USPH U.S. Physical Therapy	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Rossi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.82 +1.4%	$90.00 ➝ $95.00	Overweight
VCT Victrex	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 966.97 -3.1%	GBX 700 ➝ GBX 1,000	Neutral
VCT Victrex	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 966.97 -3.1%	GBX 680 ➝ GBX 870	Hold
VNCE Vince	Reiterated by	Noble Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.04 +0.1%		Outperform
VRNS Varonis Systems	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.74 -1.7%	$46.00	Outperform ➝ Neutral
VRTX Vertex Pharmaceuticals	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Fye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$516.81 +0.4%	$515.00 ➝ $560.00	Overweight
VSTM Verastem	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.44 -2.4%	$18.00	Buy
VSTM Verastem	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeet Mukherjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.44 -2.4%	$18.00	Buy
VTXPF Victrex	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.95		Neutral
VVV Valvoline	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.72 +1.7%	$46.00 ➝ $49.00	Outperform
WCP Whitecap Resources	Target Raised by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$18.46 -1.3%	C$18.00 ➝ C$21.00	Buy
WHR Whirlpool	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Reid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.31 -1.6%	$42.00 ➝ $39.00	Equal Weight
WHR Whirlpool	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rafe Jadrosich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$35.31 -1.6%	$38.00 ➝ $31.00	Underperform
WING Wingstop	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.96 +6.7%	$160.00 ➝ $120.00	Hold
WK Workiva	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.96 +0.9%	$70.00 ➝ $80.00	Buy
WLK Westlake	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Salvator Tiano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.66 -1.3%	$92.00	Sector Weight ➝ Overweight
WYNN Wynn Resorts	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.84 -0.7%	$145.00 ➝ $138.00	Buy
XGN Exagen	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anderson Schock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.15 +2.6%	$12.00	Buy
XNCR Xencor	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.61 +1.4%	$27.00 ➝ $35.00	Overweight
YELP Yelp	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cory Carpenter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.12 +0.8%	$19.00	Underweight
YOU CLEAR Secure	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wyatt Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.53 -0.5%	$55.00 ➝ $45.00	Neutral
ZD Ziff Davis	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Smilek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.18 +1.6%	$60.00	Neutral
ZG Zillow Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Erickson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.21 +4.2%	$55.00	Outperform
ZS Zscaler	Initiated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$163.75 +0.2%	$215.00	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:44 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings